Bromelow K V, Souberbielle B, Alavi A, Goldman J H, Libera L D, Dalgleish A G, McKenna W J
Department of Cardiological Sciences, St. George's Hospital Medical School, London, UK.
J Autoimmun. 1997 Apr;10(2):219-27. doi: 10.1006/jaut.1996.0119.
Idiopathic dilated cardiomyopathy (IDCM) is the main cause of cardiac transplantation in young adults in the 20-40 years age group in the Western world. Recent evidence supports a possible role for autoimmune pathogenesis in IDCM and it has been suggested that T cells could mediate the disease. Cardiac myosin is one of the putative autoantigens recognized by antibodies from patients with IDCM, but T cell responses to cardiac myosin have not previously been assessed. Proliferation to cardiac myosin by peripheral blood mononuclear cells (PBMC) from patients, their relatives and controls was assessed in a lymphoproliferation assay specifically designed to measure low frequency T cell precursor responses. The study group consisted of 23 patients with IDCM and 29 relatives. The control groups consisted of 10 patients with heart failure secondary to ischaemic heart disease (IHD) and 22 healthy laboratory controls. A response to myosin was observed in 16.7% of the subjects studied. However, these responses were all of low precursor frequency and no dose response for antigen-specific proliferation could be observed. More importantly, there was no correlation between myosin-specific T cell responses and IDCM, as only one IDCM patient and four IDCM relatives (three out of the four with left ventricular enlargement (LVE)) were among the 14 subjects whose PBMC exhibited a proliferative response. However, proliferation of PBMC to purified protein derivative of Mycobacterium bovis (PPD) was significantly suppressed in IDCM patients when compared with the laboratory control group (P<0.05). PPD response data suggested that the PPD suppression correlated with disease progression. The results of our present study indicate an absence, or lack, of cardiac myosin-specific peripheral blood T cells in IDCM patients, along with the possibility of underlying impaired cell mediated immunity, reflected in the suppressed responses to PPD. Future studies looking at T cell immune mechanisms in IDCM should concentrate on the analysis of T cells from the heart itself, or look at other potential cardiac antigens from normal and diseased heart tissue.
特发性扩张型心肌病(IDCM)是西方世界20至40岁年轻成年人心脏移植的主要原因。最近的证据支持自身免疫发病机制在IDCM中可能发挥的作用,并且有人提出T细胞可能介导该疾病。心肌肌球蛋白是IDCM患者抗体识别的假定自身抗原之一,但此前尚未评估T细胞对心肌肌球蛋白的反应。在专门设计用于测量低频T细胞前体反应的淋巴细胞增殖试验中,评估了患者、其亲属和对照的外周血单个核细胞(PBMC)对心肌肌球蛋白的增殖情况。研究组由23例IDCM患者和29名亲属组成。对照组由10例缺血性心脏病(IHD)继发心力衰竭的患者和22名健康实验室对照组成。在16.7%的研究对象中观察到对肌球蛋白的反应。然而,这些反应的前体频率均较低,且未观察到抗原特异性增殖的剂量反应。更重要的是,肌球蛋白特异性T细胞反应与IDCM之间没有相关性,因为在14名PBMC表现出增殖反应的受试者中,只有1例IDCM患者和4名IDCM亲属(4名中有3名有左心室扩大(LVE))。然而,与实验室对照组相比,IDCM患者的PBMC对牛分枝杆菌纯蛋白衍生物(PPD)的增殖明显受到抑制(P<0.05)。PPD反应数据表明PPD抑制与疾病进展相关。我们目前的研究结果表明,IDCM患者不存在或缺乏心肌肌球蛋白特异性外周血T细胞,同时可能存在潜在的细胞介导免疫受损,这反映在对PPD的抑制反应中。未来研究IDCM中T细胞免疫机制应集中于分析来自心脏本身的T细胞,或研究正常和患病心脏组织中的其他潜在心脏抗原。